Iodine-induced hyperthyroidism: Occurrence and epidemiology

Thyroid

Volumn 8, Issue 1, 1998, Pages 83-100

  Stanbury, J B ^a,i   Ermans, A E ^b   Bourdoux, P ^b   Todd, C ^c   Oken, E ^d   Tonglet, R ^e   Vidor, G ^f   Braverman, L E ^g   Medeiros Neto, G ^h  

^a Intl Cncl Contr Iodine DD   (United States)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c University of Zimbabwe   (Belgium)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f LAUNCESTON GENERAL HOSPITAL   (Australia)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; CONTRAST MEDIUM; CREATININE; GLUCOCORTICOID; IODINATED CONTRAST MEDIUM; IODINATED POPPYSEED OIL; IODINE; IODOPHOR; LIOTHYRONINE; LUGOL; POTASSIUM BROMATE; POTASSIUM IODATE; POTASSIUM IODIDE; POVIDONE IODINE; PROTIRELIN; SODIUM CHLORIDE; THIAMAZOLE; THYROGLOBULIN; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

AUSTRALIA; BRAZIL; CLINICAL TRIAL; CONFERENCE PAPER; DEMOCRATIC REPUBLIC CONGO; GOITER; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; IODINE DEFICIENCY; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SOUTH AMERICA; SWITZERLAND; THYROIDECTOMY; THYROTOXICOSIS; TOPICAL DRUG ADMINISTRATION; ZIMBABWE;

EID: 0031952859     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.83     Document Type: Conference Paper

References (348)

1. Ermans AM, Soron'gane EM, Tonglet R, et al. (1994 Thyrotoxicosis induced by consumption of highly iodinated salt in a severely iodine deficient population in Kivu [abstract]. J Endocrinol Inv 17:(supp 1)
2. Ermans AM, Gullo D, Mugisho SG, et al. (1995) Iodine supplementation must be monitored at the population level in iodine deficient areas [abstract]. Thyroid 5:137.
3. Bourdoux PP, Ermans AM, Mukalay A, et al. 1996 Iodine-induced thyrotoxicosis in Kivu, Zaire [letter]. Lancet 347:552-553.
4. Todd CH, Allain T, Gomo AZR, Haster JA, et al 1995 Increase in thyrotoxicosis associated with iodine supplements in Zimbabwe [letter]. Lancet 346:1563.
5. WHO 1997 Recommended Iodine Levels in Salt and Guidelines for monitoring their adequacy and effectiveness. WHO, Division of Nutrition, Geneva, 1997.
6. Bourdoux P, Ermans A, Murkalay A 1996 Recommendations concerning iodine prophylaxis [letter]. Eur J Endocrinol 133:764.
7. Coindet JF 1820 Decouvete d'un remede contrele goitre. Ann de chim et Phys 15:49.
8. Coindet JF 1821 Nouvelles recherches sur les effets de l'iodide et sur les precises le traitment du goitre par ce nouveau remede. Ann de chim et phys 16:3.
9. Gairdner W 1824 Essay on the effects of iodine & c. Quoted from Magendie Formulaire, translated from the 3rd French edition by Robley Duglison. Philadelphia.
10. Parry CH 1825 I. Enlargement of the thyroid gland in connection with enlargement or palpitation of the heart. II. Bronchocele, with affections of the head. Collections from the unpublished medical writings of the late Caleb Hillier Parry. London, II, III-125; 125-129.
11. Rilliet F 1860 Memoire sur l'iodisme constitutionnel. Masson, Paris.
12. Breuer R 1900 Beitrag zur aetiologie der Basedos'schen krankheit and des thyreoidismus. Wien Klin Woch 13:671.
13. Kocher T 1910 Ueber jodbasedow. Arch f Klin Chir 92:1166.
14. Marine D, Kimball OP 1917 The prevention of simple goiter in man. J Lab Clin Med 3:40.
15. Plummer HS 1928 The function of the thyroid gland containing ademomatous tissue. Tr Assoc Am Phys 43:159.
16. Webster B, Clawson TA, Chesney AM 1928 Endemic goitre in rabbits. II. Heat production in goitrous and non-goitrous animals. Bull J Hopkins Hosp 43:278.
17. Webster B, Chesney AM 1928 Endemic goitre in rabbits III. Effect of administration of iodine. Bull J Hopkins Hosp 43:291.
18. Rawson RW 1948 Tumors of the thyroid. In: Means JH (ed) The Thyroid. Lippincott, Philadelphia, pp. 446-468.
19. Clute HM, Pilcher LS 1934 The place of iodine in the treatment of goiter. N Engl J Med 210:117.
20. Werner R 1952 Nil nocere! beobachtungen uber Jodbasedow. Munch Med Woch 94:2436.
21. Zimmermann H 1931 Zur Haufigkeit von jodthyreotoxikosen und vollsalzschadigungen. Munch Med Woch 78:52.
22. May R 1953 Jodprophylaxe mit vollsalz und Jodbasedow. Munch Med Wschr 95:1173.
23. Vaginakis AG, Braverman LE 1975 Adverse effects of iodides on thyroid function. Med Clin North Am 50:1075.
24. Vagenakis AG, Wang CA, Burger A, Maloof F, Braverman LE, Ingbar SH 1972 Iodide-induced thyrotoxicosis in Boston. N Engl J Med 287:523.
25. Wolff J 1969 Iodide goiter and the pharmacologic effects of excess iodide. Am J Med 47:101.
26. Fradkin JE, Wolff J 1983 Iodide-induced thyrotoxicosis. Medicine 62:1.
27. Braverman LE 1994 Iodine and the thyroid: 33 years of study. Thyroid 4:351.
28. Laroche G, Hirsch M 1960 Les troubles thyroidiens d'origine iodee: goitre, iode-myxoedeme, iode-Basedow. Presse Medicale 68:2119.
29. Kobberling J, Hintze G 1985 Diagnostic problems in iodine induced thyrotoxicosis. In Hall R, Kobberling J (eds) Thyroid Disorders Associated with Iodine Deficiency and Excess. Raven, New York, p. 419.
30. Hetzel BS 1980 Iodine-induced thyrotoxicosis (jodbasedow). In: Stanbury JB, Hetzel BS (eds). Endemic Goiter and Endemic Cretinism. Wiley, New York, p. 562.
31. Pennington JAT 1990 A review of iodine toxicity reports. J Am Diet Assoc 90:1581.
32. Hall R, Kobberling J (eds) 1983 Thyroid Disorders Associated with Iodine Deficiency and Excess. Raven, New York.
33. Journal of Molecular Medicine, vol. 4, 1980.
34. Editorial 1972 Iodide-induced thyrotoxicosis. Lancet 2:1072.
35. Utiger RD 1972 The diverse effects of iodide on thyroid function [editorial]. N Engl J Med 287:562.
36. Braverman LE, Utiger RD 1991 The Thyroid and its Diseases, 6th ed. Lippincott, Philadelphia.
37. 36a. Alexander WD, Harden RM, Koutras DA, Wayne E 1965. Influence of iodine intake after treatment with antithyroid drugs. Lancet 2:866.
38. Delange F 1994 The disorders induced by iodine deficiency. Thyroid 4:107-128.
39. Phillips DIW, Barker DSP, Winter PD, Osmond C 1983 Mortality from thyrotoxicosis in England and Wales and its association with the previous prevalence of endemic goitre. J Epidemiol Community Health 37:305.
40. Bonnyns M, Bourdoux P 1988 Delayed control of iodine-induced thyrotoxicosis with a thionamide after KClO4 withdrawal [letter]. J Endocrinol Invest 11:393.
41. Meulengracht E 1949 Epdemiologic aspects of thyrotoxicosis. Arch Intern Med 83:119.
42. Meulengracht E 1945 Increasing incidence of hyperthyroidism in Denmark. Acta Med Scand 121:446.
43. Berglund J, Ericksson U-B, Hallengren B 1996 Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974. J Internat Med 239:57.
44. Phillips DI, Nelson M, Barker DJ, Morris JA, Wood TJ 1988 Iodine in milk and the incidence of thyrotoxicosis in England. Clin Endocrinol 28:61.
45. Kohn LA 1975 A look at iodine-induced hyperthyroidism: Recognition. Bull NY Acad Med 51:959.
46. Kohn LA 1976 The midwestern American "epidemic" of io-dine-induced hyperthyroidism in the 1920's. Bull NY Acad Med 52:770.
47. McClure RD 1934 Thyroid surgery as affected by the generalized use of iodized salt in an endemic goiter region-Preventive surgery. Ann Surg 100:924.
48. McClure RD 1934 Thyroid surgery in southern Michigan as affected by the generalized use of iodized salt. J Mich Med Soc 33:58.
49. McClure RD 1927 Experiences with the thyroid problem in a Detroit clinic. Ann Surg 85:333.
50. Marine D, Lenhart CH 1909 Effects if administration or the withholding of iodin-containing compounds in normal colloid or actively hyperplastic (parenchymatous) thyroids of dogs. Arch Intern Med 4:293.
51. Marine D, Kimball OP 1917 A survey of the incidence and types of thyroid enlargements in the schoolgirls of Akron (Ohio), from the 5th to the 12th grades, inclusive - The plan of prevention proposed. J Lab Clin Med 3:40.
52. Marine D, Kimball OP 1917 The prevention of simple goiter in man. J Lab Clin Med 3:40.
53. Marine D, Kimball OP 1921 Prevention of simple goitre in man. JAMA 77:1068.
54. Marine D 1935 The pathogenesis and prevention of simple or endemic goiter. J Am Med Assoc 104:2334.
55. Kimball OP 1922 The prevention of simple goiter in man. Am J Med Sci 163:634.
56. Kimball OP 1925 Induced hyperthyroidism. JAMA 85:1709.
57. Jackson D 1924 Iodine as a cause of hyperthyroidism with a report of eighteen cases. Lancet 44:324.
58. Jackson AN 1925 Iodine hyperthyroidism. An analysis of fifty cases. Bos Med Surg J 103:1138.
59. Jackson AS, Freeman HE 1936 The effect of iodine in adenomatous goiter. JAMA 106:1261.
60. Goetsch E 1934 Correct and incorrect use of iodine in the treatment of goiter. Am J Surg 26:417.
61. Hartsock CL 1926 Iodized salt in the prevention of goiter. JAMA 86:1334.
62. Hartsock CL 1927 Abuse of iodine, especially of iodized salt, in the prevention of goiter. Ann Intern Med 1:24.
63. Kobberling J, Hintze G, Blossey HC, et al 1981 Diagnostische probleme der hyperthyreose im hoheren lebensalter. D Med Wschr 106:973.
64. Lahey FH 1931 Apathetic thyroidism. Ann Surg 93:1026.
65. 63a. Pittman JA, Dailey GE 1969 Changing normal values for thyroid radioiodine uptake. N Engl J med 280:1969.
66. Gibson HB 1995 Surveillance of iodine deficiency disorders in Tasmania 1949-1984, Privately printed, Department of Health Services, Hobart, Tasmania.
67. Stewart JC, Vidor GI, Buttfield IH, Hetzel BS 1971 Epidemic thyrotoxicosis in northern Tasmania: Studies of clinical features and iodine nutrition. Aust N Z J Med 3:203.
68. Stewart JC 1975 Epidemiology and pathogenesis of iodine-induced thyrotoxicosis in northern Tasmania. N Z Med J 81:25.
69. Stewart JC, Vidor GI 1976 A common unrecognized condition? Br Med J 1:372.
70. Vidor G, Stewart JC, Wall JR, et al 1973 Pathogenesis of iodine-induced thyrotoxicosis: Studies in northern Tasmania. J Clin Endocrinol Metab 31:901.
71. Vidor G 1996 Personal communication.
72. Connolly RJ 1972 The changing age incidence of jodbasedow in Tasmania. Med J Austral 2:171.
73. Hetzel BS 1980 The occurrence of iodine induced thyrotoxicosis in Tasmania. In: Stanbury JB, Hetzel BS (eds) En-demic Goiter and Endemic Cretinism. Wiley, New York, p. 127.
74. Connolly RJ, Vidor GI, Stewart JC 1970 Increase in thyrotoxicosis in endemic goitre area after iodation of bread. Lancet i:500.
75. Vidor G, Hetzel B, Buttfield IH, et al 1968 Studies of thyrotoxicosis in Tasmania [abstract]. Austral Ann Med 117:62.
76. Clements FW, Gibson HB, Howeler-Coy JF 1970 Goitre prophylaxis by addition of potassium iodate to bread. Lancet i:489.
77. Connolly RJ 1971 An increase in thyrotoxicosis in southern Tasmania after an increase in dietary iodine. Med J Austral i:1268.
78. Adams DD, Kennedy TH, Stewart JC, et al 1975 Hyperthyroidism in Tasmania following iodide supplementation: Measurements of thyroid-stimulating autoantibodies and thyrotropin. J Clin Endocrinol Metab 41:221.
79. Tasmanian Thyroid Advisory Committee 1981 Study in disease surveillance 1950-1979. Med J Aust 2:234.
80. Ingbar SH 1972 Autoregulation of the thyroid. Mayo Clin Proc 47:874.
81. Communique. 1995 Recommendations concerning iodine prophylaxis. Eur J Endocrinol 133:764.
82. Kelly FC, Snedden WW 1960 Prevalence and geographical distribution of endemic goitre. In: Clements FW, DeMoerloose DE, De Smet MP, et al. (eds) Endemic Goitre. WHO, pp. 27-233.
83. Chinamora Research Team 1986 Endemic goitre in Chinamora, Zimbabwe. Lancet i:1198.
84. Todd CH, Bourdoux P 1991 Severe iodine deficiency in two endemic goitre areas of Zimbabwe. Cent Afr J Med 37:237.
85. Thomas JEP 1990 Iodine deficiency disorders-What importance to Zimbabwe [editorial]? Cent African J Med 36:180.
86. Merke F 1971 Geschichte und ikonographie des endemischen kropfes und kretinismus. Huber, Bern.
87. Nicod JL 1953 Le goitre, endemique en Suisse et sa prophylaxie par le sel iode. Bull Org Mond Sante 9:259.
88. Mach R-S 1973 L'iode-Basedow, probleme toujours d'actualite. Schweiz med Wsch 103:1481.
89. Wagner-Jauregg 1931 Die angeblichen schilddruksenschadigungen durch vollsaz. Wien Klin Woch 44:317.
90. Burgi H, Supersaxo Z, Selz B 1990 Iodine deficiency diseases in Switzerland one hundred years after Theodor Kocher's survey: A historical review with some new goitre prevalence data. Acta Endocrinol 123:577.
91. Als C, Listewnik M, Rosler H, Bartkowiak E 1995 Immunogenic and nonimmunogenic hyperthyroidism. Nuklearmedizin 34:92.
92. Baltisberger BL, Minder CE, Burgi H 1995 Decrease in incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 132:546.
93. Lima N, Medeiros-Neto G 1984 Transient thyrotoxicosis in endemic goitre patients following exposure to a normal iodine intake. Clin Endocrinol 21:631.
94. Martins C, Lima N, Knobel M, Medeiros-Neto G 1989 Natural course of iodine-induced thyrotoxicosis (jodbasedow) in endemic goiter area: A 5 year follow-up. J Endocrinol Invest 12:239.
95. Maberly GF, Corcoran JM, Eastman CJ 1982 The effect of iodized oil on goitre size, thyroid function and the development of the jod basedow phenomenon. Clin Endocrinol 17:253.
96. Stanbury JB, Brownell GL, Riggs DS, et al 1984 Endemic Goiter: The Adaptation of Man to Iodine Deficiency. Harvard University Press, Cambridge, MA, p. 66.
97. Wanatabe T, Moran D, El Tamera E, et al 1974 Iodized oil in the prophylaxis of endemic goiter in Argentina. In: Dunn JT, Medeiros G (eds) Endemic Goiter and Cretinism: Continuing Threats to World Health. PAHO Scientific Publication No. 292, PAHO, Washington, DC, p. 231.
98. Croxon MS, Gluckman PD, Ibbertson HK 1976 The acute thyroidal response to iodized oil in severe endemic goiter. J Clin Endocrinol Metab 42:926.
99. Fierro-Benitez R, Ramirez I, Estrella E, et al 1969 Iodized oil in the prevention of endemic goiter and associated defects in the Andean region of Ecuador. Stanbury JB (ed) PAHO Scientific Publication No. 193., Washington, DC, p. 306.
100. Kevany J, Fierro-Benitez R, Pretell EA, Stanbury JB 1969 Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. Am J Clin Nut 22:1597.
101. Zanzi I, Bradford I, Cordova J 1973 Aspectos epidemiologicos del hypertiroidismo en Chile. Rev Med Chile 100:1055.
102. Montecinos LA, Arias D, Larenas G, et al 1980 Epidemia de hipertiroidismo en la IX Region. 2nd Congreso Chilene de Endocrinologia, Diabetes y Metabolism, Santiago [abstract], p. 30.
103. Pineda G 1983 lodoprophylaxis and hyperthyroidism. Presented at the 11th Latin American Thyroid Congress. Lima, Peru.
104. Van Leeuwen E 1954 Een vorm van genuine hyperthyreose (M. Basedow zonder exophthalmus) na gebruik van gejodeerd brood. Ned Tijdschr Geneesk 98:81-89.
105. Riccabona, G 1993 Status of iodine nutrition in Europe: National update, Austria. In: Delange F, Dunn JT, Glinoer D (eds) Iodine Deficiency in Europe: A Continuing Concern. Plenum, New York, p. 373.
106. Riccabona G, Glatzl J, Platzer S, et al 1981 Gibt es noch eine kropfendemie bei Osterreichs Jugend? Pediatrie Padologie 16:180.
107. Riccabona G 1996 Personal communication.
108. Galofre L, Fernandez-Calvet M, Rios M, Garcia-Mayor RVG 1994 Increased incidence of thyrotoxicosis after iodine supplementation in an iodine sufficient area. J Endocrinol Invest 17:23.
109. Kiceic M 1977 Problemi hypertireoze uk toku uvedenia jodne profilakse endemske tiropatske distrofige. Vojnosanit. Pregl. 34:409, and Kusic Z 1996 Personal communication.
110. Kiceic M 1977 Problemi hypertireoze uk toku uvedenia jodne profilakse endemske tiropatske distrofige. Vojnosanit. Pregl. 34:409, and Kusic Z 1996 Personal communication.
111. Elnager B, Eltom M, Karlsson FA, et al 1995 The effects of different doses of oral iodized oil on goiter size, urinary iodine, and thyroid-related hormones. J Clin Endocrinol Metab 80:890.
112. Hintze G, Kobberling J, Becker HD, Kobberling G 1985 Subtotal thyroidectomy - A rational alternative in severe, iodine induced thyrotoxicosis. In: Hall R, Kobberling J (eds) Thyroid Disorders Associated with Iodine deficiency and Excess. Raven, New York, p. 415.
113. Benoit G, Wemeau JL, Dedoulx M, et al 1980 L'iode dans l'induction et dans la revelation des hyperthyroidies. Lille Med 25:329-335.
114. Seif FJ 1991 Hyperthyreosen nach jodhaltigem speisesaltz? Deutch Med Woch 116:794.
115. De Filippi V, Patrito G, Torrengo S, et al 1985 Iodine-induced thyrotoxicosis. Report of 51 patients. In: Hall R, Kobberling J (eds) Thyroid Disorders Associated with Iodine Deficiency and Excess. Raven, New York, p. 399.
116. Klaua M, Bauch K, Ulrich FE, Hansgen K 1991 Hyperthyreoseinzidenz im bezirk Halle vor und nach einfuhrung der algemeinen iodprophylaxe. Z Gesamte Inn Med 46:573.
117. Schroeder F 1989 Hyperthyreose manifestation vor und nach alimentarer jodkomplettierung. Verlaufsuntersuchungen in Brandenburg 1983-1988. Z Gesamete Inn Med 44:229.
118. Als C, Lauber K, Brander L, et al 1995 The instability of dietary iodine supply over time in an affluent society. Experentia 51:25.
119. Paul T, Meyers B, Witorsch RJ, et al 1988 The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metab Clin Exp 37:121.
120. Beckers C 1985 Frequency of iodide-induced thyrotoxicosis after iodine administration. In: Hall R, Kobberling J (eds) Thyroid Disorders Associated with Iodine Deficiency and Excess. Raven, New York, p 369.
121. Trost RN, Buchli R, Osterwalder HJ, et al 1980 The handling of moderately excessive iodide loads by normal and goitrous human thyroid glands. J Mol Med 4:167.
122. Ermans AM, Verelst J 1980 Acute effects of supra-physiological doses of iodide in the human being: Management of non-toxic goiter. J Mol Med 4:199.
123. Thilly CH, Lagase R, Bourdoux P, Ermans AM 1980 High dose iodine prophylaxis in severe endemic goiter. A balance of risks. J Mol Med 4:191.
124. Koutras DA 1980 Clinical aspects of excess iodine in iodine deficiency. J Mol Med 4:139.
125. Joseph K, Mahlstedt J, Gonnermann R, et al 1980 Early recognition and evaluation of the risk of hyperthyroidism in thyroid autonomy in an endemic goitre area. J Mol Med 4:21.
126. Hamilton CR, Maloof F 1973 Unusual types of hyperthyroidism. Medicine 52:195.
127. Spaulding SW, Burrow GN, Ramey JN, Donabedian RK 1977 Effects of increased iodide intake on thyroid function in subjects on chronic lithium therapy. Acta Endocrinol 84:290.
128. Preuschof L, Keller F, Bogner U, et al 1991 Plasma exchange and hemoperfusion in iodine-induced thyrotoxicosis. Blood Purif 9:164.
129. Hennen G, Mary-Rabine L, Meurisse M 1992 Hyperthyroidies severes induites par l'iode: une urgence medicochirurgicale. Rev Med Liege 47:237.
130. Oswald A 1922 Zir Kropfprophylaxe. Schweiz Med Woch 3:313.
131. de Quervain P 1929 Zur schweizerischen basedow-statistik. Schweisz Med Woch 9:2.
132. de Quervain P 1929 Zur kropfprophylaxe durch jodkochsalz. Schweisz Med Woch 10:1099.
133. Scrimshaw NS, Cabezas A, Castillo F, Mendez J 1953 Effect of potassium iodate on endemic goitre and protein-bound iodine levels in school-children. Lancet ii:166.
134. Thomas WC, Malagodi MH, Oates, McCourt JP 1978 Effects of an iodinated water supply. Trans Am Clin Climatol Assoc 90:153.
135. Freund G, Thomas WC, Bird ED, et al 1966 Effects of iodinated water supplies on thyroid function. J Clin Endocr 26:619.
136. Savoie JC, Massin JP, Thomopoulos P, Leger F 1975 Iodine-induced thyrotoxicosis in apparently normal thyroid glands. J Clin Endocrinol Metab 41:685.
137. Savoie JC, Leger F-A, Massin J-P, et al 1976 L'hyperthyroidie induite par l'iodide sur une glande thyroide apparament normal. Nov Presse Medicale 5:2593.
138. Sobrinho LG, Limbert ES, Santos MA 1977 Thyroxine toxicosis in paients with iodine induced thyrotoxicosis. J Clin Endocrinol Metab 45:25.
139. Miller HA, Farley JA, Major DA 1981 Topical iodine and hyperthyroidism. Ann Intern Med 95:120.
140. Shetty KR, Duthie EH 1990 Thyrotoxicosis induced by topical iodine application. Arch Intern Med 150:2400.
141. Jacobson JM, Hankins GV, Murray JM, Young RL 1981 Self-limited hyperthyroidism following intravaginal iodine administration. Am J Obstet Gynecol 140:472.
142. King IR, Diddle AW 1970 Protein-bound iodine and T4 tests after vaginal application of providone-iodine. Am J Obstet Gynecol 108:1175.
143. Reith PE, Granner DK 1985 Iodine-induced thyrotoxicosis in a woman with a multinodular goiter taking levothyroxine. Arch Intern Med 145:355-356.
144. Mumenthaler H, Aeberhard P 1982 Der Einfluss der intraperitonealen lavage mit polyvinlylpyrrolidon-jod auf den jodgehalt des serums und die schildrdrusenfunction. Helv Chir Acta 49:99.
145. Andre F, Bielefeld P, Besancenot JF, et al 1988 Fausse innocuite des collyres. A propos d'une observation de thytoxicose induie par l'iode. Therapie 43:431.
146. Lividas DP, Koutras DA, Souvatzoglou A, Beckers C 1977 The toxic effects of small iodine-supplements in patients with autonomous thyroid nodules. Clin Endocrinol 7:121.
147. Ermans AM, Camus M 1972 Modifications of thyroid function induced by chronic administration of iodine in the presence of "autonomous" thyroid tissue. Acta Endocrinol 70:463.
148. WHO Fact Sheet No. 121, May, 1996.
149. Clugston G, Beaudry M, Delange F 1996 Iodine-induced thyrotoxicosis. Lancet 347:1051.
150. Skare S, Frey HMM 1980 Iodine induced thyrotoxicosis in apparently normal thyroid glands. Acta Endocrinol 94:332.
151. Leger AF, Massin JP, Laurent ME, et al 1984 Iodine-induced thyrotoxicosis: Analysis of eighty-five consecutive cases. Eur J Clin Invest 14:449.
152. Pickardt CR 1982 Iodinduzierte hyperthyreose. Deutsch Med Woch 107:1219.
153. Camus J-P, Prier A, Kartun P, et al 1973 Thyreotoxicose et benziodarone. Rev du Rhumatisme 40:148-150.
154. Braverman LE 1990 Iodine induced thyroid disease. Acta Med Austriaca 17(Suppl 1):29.
155. Herrmann J 1991 Prophylaxe und therapie der jodinduzierten hyperthyreose. Dtsch Med Wochenschr 116:99.
156. Surks MI, Sievert R 1995 Drugs and thyroid function. N Engl J Med 333:1689.
157. Kallee E, Wahl R, Bohner J, et al 1980 Thyrotoxicosis induced by iodine-containing drugs. J Mol Med 4:221.
158. Weissel M 1988 Suppression of thyroglobulin secretion in amiodarone iodine-induced thyrotoxicosis. J Endocrinol Invest 11:53.
159. Joly J 1976 Hyperthyroidies medicamenteuses. Rev du Praticien 26:55.
160. Shilo S, Hirsch HJ 1986 Iodine-induced hyperthyroidism in a patient with a normal thyroid gland. Postgrad Med J 62:661.
161. De Smet PA, Stricker BH, Wilderink F, Wiersinga WM 1990 Hyperthyreoidie tijdens het gebruik van kelptabletten. Ned Tijdschr Geneeskd 134:1058.
162. Liewendahl K, Gordin A 1974 Iodine-induced toxic diffuse goitre. Acta Med Scand 196:237.
163. Husaby JS, Bennett SW, Hagensee ME 1991 Hyperthy-roidism induced by iodinated glycerol. Am Rev Respir Dis 144:1403.
164. Petty TL 1990 Results of a randomized, double-blind placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest 97:74.
165. Becker CB, Gordon JM 1993 Iodinated glycerol and thyroid dysfunction. Chest 103:188.
166. Liel Y, Alkan M 1997 "Traveler's thyrotoxicosis". Thyrototoxicosis due to an iodinated preparation for water purification. Ann Int Med. In press.
167. LeMar HJ, Georgitis WJ, McDermort MT 1995 Thyroid adaptation to chronic tetraglycine hydroperiodide water purification tablet use. J Clin Endocrinol Metab 90:220.
168. Rajatanavin R, Safran RM, Stoller WA, et al 1984 Five patients with iodine-induced hyperthyroidism. Am J Med 77:378
169. Jorgensen H, Svindland O 1991 Hyper-og hypotyreose etter bruk av jodholdige "naturprodkter" og jodholdige vitamin-og mineraltilskudd. Tidsskr Nor Laegeforen 111:3153.
170. Block MB, DeFrancesco SJ 1979 Hyperthyroidism possibly induced by iodine in a multivitamin. Ariz Med 36:510.
171. Chagnon A, Longuet D, Melin RL 1978 L'hyperthyroidie iatrogene d'expression differee. Une entite physiopathologique? Bourdoux Med 18:1603.
172. Herxheimer H 1977 Effect of iodide treatment on thyroid function [letter]. N Engl J Med 297:171.
173. Ahmed M, Doe RP, Nuttall FQ 1974 Triiodothyronine thyrotoxicosis following iodide ingestion: A case report. J Clin Endocrinol Metab 38:574.
174. Benoit G, Wemeau JL, Decoulx M, et al 1989 L'iode dans Pinductionet dans la revelation des hyperthyroidies. Lille Med 25:329.
175. Gutknecht DR 1977 Asthma complicated by iodine-induced thyrotoxicosis [letter]. N Engl J Med 296:1237.
176. Ek B, Johnsson S, von Porat B 1963 Iodine repletion test in an endemic goitre area. Risk of iodine-induced hyperthyroidism. Acta Med Scand 173:3241.
177. Bryant WP, Zimmerman D 1995 Iodine-induced hyperthyroidism in a newborn. Pediatrics 95:434.
178. Yoshinari M, Tokuyama T, Okamura K, et al 1988 Iodide-induced thyrotoxicosis in a thyroidectomized patient with metastatic thyroid carcinoma. Cancer 61:1674.
179. 3-hyperthyreose beim metastastierenden follikularen schilddrusenkarzinom. Nuklearmedizin 25:201.
180. Mahlestedt J, Fischer H, Joseph K 1980 Thyroidal uptake, thyroid regulation and concentrations of thyroid hormones in thyroid autonomy after administration of iodine-containing contrast media. J Mol Med 4:203.
181. Philippe P, Aumaitre O, Andre P, et al 1986 Les dysthyroidies secondaires aux medicaments iodes. Therapkie 41:135.
182. Silas AM, White AG 1975 Hyperthyroidism after use of contrast medium [letter]. Br Med J ii:162.
183. Blum M, Weinberg U, Shenkman L, Hollander CS 1974 Hyperthyroidism after iodinated contrast medium. N Engl J Med 291:24.
184. Steidle B 1979 Iodinduzierte hyperthyreose durch kontrastmittel. Deut Med Woch 104:1435.
185. Steidel B 1989 Iodine-induced hyperthyroidism after contrast media: Animal experimental and clinical studies. Fortsch Geb Rontg Nuk Erganiz 128:16.
186. Burgi H, Wimpfheimer C, Burger A, et al 1976 Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 43:1203.
187. de Bruin TWA 1994 Iodide-induced hyperthyroidism with computed tomography contrast fluids. N Engl J Med 343:1160.
188. Herrmann J, Kruskemper HL 1978 Gefahrdung von patienten mit latenter und manifester hyperthyreose durch jodhaltige rontgenkontrastmittel und medikamente. D Med Wschr 103:1434.
189. Hanaghan J, Dhupella D, Finucane J 1979 Thyroid hormones in serum: Effects of x-ray contrast media. Ir J Med Sci 148:12.
190. Schneider C, Stephan G, Suwelack M 1969 Uber das hyperthyreose-risko bei iatrogener iodzufuhr. Deutsche Med Woch 19 Dec 84:2631.
191. Martin FI, Tress BM, Colman PG 1993 Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. Am J Med 95:78.
192. Seilf FJ, Stockle G, Grehn S, Steidle B 1980 Changes of thyroid hormones, thyrotropin, and prolactin after application of iodinated radiographic media in patients of an endemic goiter area. J Mol Med 4:211.
193. Scriba PC 1984 Probleme des Jodmangels bzw. des Jodexzesses. Therapiewoche 34:2718.
194. Shetty SP, Murthy GG, Shreeve WW, et al 1974 Hyperthyroidism after pyelography [letter]. N Engl J Med 291:682.
195. Allanic H, Lorcy Y, Leverger JC, Vivien P 1976 Hyperthyroidie apres urographie intra-veneuse [letter]. Nov Press Med 5:2167.
196. Beng CG, Wellby MI, Symons RG, et al 1980 The effects of iopodate on the serum-iodothyronine pattern in normal subjects. Acta Endocrinol 93:175.
197. Fairhurst BJ, Naqvi N 1975 Hyperthyroidism after cholecystography [letter]. BJ 3:430.
198. Wu P-Y, Chopra IJ, Solomon DH, Bennett LR 1978 Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J Clin Endocrinol Metab 46:691.
199. Mann K, Rend J, Busley R, et al 1994 Systemic iodine absorption during endoscopic application of radiographic contrast agents for endoscopic retrograde cholangiopanacreaticography. Eur J Endocrinol 130:498.
200. Benker G, Vosskuhler A, Hoff HG, et al 1983 Thyroid function after bronchography with propyliodine. Horm Res 17:121.
201. Vosskuhler GA, Hoff HG, et al 1983 Thyroid function after bronchography with propyliodine. Horm Res 17:121.
202. Blum M, Kranjac T, Park CM, Engleman RLM 1976 Thyroid storm after cardiac angiography with iodinated contrast medium. JAMA 235:2324.
203. Fritzsche H, Benzer W, Furlan W, et al 1993 Zur Vorbeugung jodinduzierte hyperthyreosen nach koronarangiographie. Acta Med Austriaca 20:13.
204. Posner J, Sobel RJ, Click S 1984 Effect of amiodarone on thyroid hormone economy. Isr J Med Sci 20:113; see also; Massey TE, Leeder RG, Rafeiro E, Brien JF 1995 Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity. Can J Physiol Pharm 73:1675; and Holt DW, Tucker GT, Jackson PR, Storey GCA 1983 Amiodarone pharmacokinetics. Am Heart J 106:840.
205. Posner J, Sobel RJ, Click S 1984 Effect of amiodarone on thyroid hormone economy. Isr J Med Sci 20:113; see also; Massey TE, Leeder RG, Rafeiro E, Brien JF 1995 Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity. Can J Physiol Pharm 73:1675; and Holt DW, Tucker GT, Jackson PR, Storey GCA 1983 Amiodarone pharmacokinetics. Am Heart J 106:840.
206. Posner J, Sobel RJ, Click S 1984 Effect of amiodarone on thyroid hormone economy. Isr J Med Sci 20:113; see also; Massey TE, Leeder RG, Rafeiro E, Brien JF 1995 Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity. Can J Physiol Pharm 73:1675; and Holt DW, Tucker GT, Jackson PR, Storey GCA 1983 Amiodarone pharmacokinetics. Am Heart J 106:840.
207. Rao RH, McCready VR, Spathis GS 1986 Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 62:563.
208. Kannan RM, Ookhtens M, Chopra IJ, Singh BN 1984 Effects of chronic administration of amiodarone on kinetics of metabolism of iodothyronines. Endocrinology 115:1710.
209. Kannan R, Nademanee K, Hendrickson JA, et al 1982 Amiodarone kinetics after oral doses. Clin Pharm Therap 31:438.
210. Broekhuysen J, Laruel R, Sion R 1969 Etude comparee du transit et du metabolisme de l'amiodarone chez diverses especes animales et chez l'homme. Arch int Pharmacodyn 177:340; see also ibid, 172:340.
211. Broekhuysen J, Laruel R, Sion R 1969 Etude comparee du transit et du metabolisme de l'amiodarone chez diverses especes animales et chez l'homme. Arch int Pharmacodyn 177:340; see also ibid, 172:340.
212. Martino E, Aghini-Lombardi F, Mariotti S, et al 1987 Amiodaroneiodine-induced hypothyroidism: Risk factors and follow-up in 28 cases. Clin Endocrinol 26:227.
213. Lambert M, Unger J, De Nayer P, et al 1990 Amiodarone-induced thyrotoxicosis suggestive of thyroid damage. J Endocrinol Invest 13:527.
214. Kennedy RL, Griffiths H, Gray TA 1989 Amiodarone and the thyroid. Clin Chem 35:1882.
215. Anderson ED 1981 Long-term antiarrhythmic therapy with amiodarone. High prevalence of thyrotoxicosis [abstract]. Eur Ht J 2(suppl A):199.
216. Trip MD, Duren DR, Wiersinga WW 1994 Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. Br Heart J 72:266.
217. Jonckheer MH 1981 Amiodarone and the thyroid gland. A review. Acta Cardiol 36:190.
218. Mason JW 1987 Amiodarone. N Engl J Med 316:455.
219. Gammage MD, Franklyn JA 1987 Amiodarone and the thyroid. QJM 62:83.
220. Figge HL, Figge J 1990 The effects of amiodarone on thyroid hormone function: A review of the physiology and clinical manifestations. J Clin Pharmacol 30:588.
221. Mechlis S, Lubin E, Laor J, et al 1987 Amiodarone-induced thyroid gland dysfunction. Am J Cardiol 59:833.
222. Martino E, Baschieri L, Aghini-Lombardi F, et al 1984 Successful treatment of amiodarone-associated thyrotoxicosis with KC1O4 and methimazole [abstract]. Ann d' Endocrinol 45:15.
223. Martino E, Aghini-Lombardi F, Mariotti S, et al 1987 Amiodarone: A common source of iodine-induced thyrotoxicosis. Horm Res 26:158.
224. Kaptein EM, Egodage PM, Hoopes MT, Burger AG 1988 Amiodarone alters thyroxine transfer and distribution in humans. Metabolism 37:1107.
225. Amico JA, Richardson V, Alpert B, Klein I 1984 Clinical and chemical assessment of thyroid function during therapy with amiodarone. Arch Intern Med 144:487.
226. Balzano S, Sau F, Bartalena L, et al 1987 Diagnosis of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with severe nonthyroidal illness. J Endocrinol Invest 10:589.
227. Staubli M, Studer H 1985 Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis. Klin Woch 63:168.
228. Aanderud S, Sundsfjord J, Aarbakke J 1984 Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes. Endocrinology 115:1605.
229. Reichert LJM, de Rooy HAM 1989 Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ 298:1547.
230. Allhaus B, Bucher J, Schon S, Vogt T 1988 Therapieresistenz einer amiodaroneinduzieralen hyperthyreose. Schweiz med Wschr 118:1176.
231. Leger AF, Fragu P, Rougler P, et al 1983 Thyroid iodine content measured by X-ray fluorescence in amiodarone-induced thyrotoxicosis. J Nucl Med 24:582-585.
232. Martino E 1987 Amiodarone: A common source of iodine-induced thyrotoxicosis. Horm Res 26:158-171.
233. Beddows SA, Page SR, Taylor AH, et al 1989 Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem Pharmacol 38:4397-4403.
234. Beddows SA, Taylor AH, G. St J. Whitley, et al 1988 Acute cytotoxic effect of amiodarone and desethylamiodarone on a human thyrocyte line (SGHTL-34 cells). J Endocrinol 119(suppl):66.
235. Bartalena L, Grasso L, Brogioni S, et al 1994 Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 78:423.
236. Smyrk TC, Goellner JR, Brennan MD, Carney JA 1987 Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 11:197; see also: Roti E, Minelli R, Gardini E, et al 1993 Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. Arch Intern Med 153:886-892.
237. Smyrk TC, Goellner JR, Brennan MD, Carney JA 1987 Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 11:197; see also: Roti E, Minelli R, Gardini E, et al 1993 Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. Arch Intern Med 153:886-892.
238. Adams PC, Holt DW, Storey BCA, et al 1985 Amiodarone and its desethyl metabolite: tissue distribution and morphologie changes during long-term therapy. Circulation 72:1064-1075.
239. Cappiello E, Boldorini R, Tosoni A, et al 1995 Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis. J Endocrinol Invest 18:862.
240. Martino E, Macchia E, Aghini-Lombardi F, et al 1986 Is humoral thyroidautoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)? Clin Endocrinol 24:627.
241. Simon C, Schlienger JL, Cherfan J, et al 1985 Efficate de la dexamethasone dans le traitement de l'hyperthyroidie a l'amiodarone [letter]. Presse Medicale 13:2767.
242. Broussolle C, Ducottet X, Martin C, et al (1989) Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced
243. Rabinowe SL, Larsen PR, Antman EM, et al 1986 Amiodarone therapy and autoimmune thyroid disease. Am J Med 81:53; see also: Monteiro E, Galvao-Teles A, Santos ML, et al 1986 Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. BMJ 292:227; and Foresti V, Parisio E, Scolari N, et al 1985 Amiodarone and antithyroid antibodies. Ann Intern Med 103:158.
244. Rabinowe SL, Larsen PR, Antman EM, et al 1986 Amiodarone therapy and autoimmune thyroid disease. Am J Med 81:53; see also: Monteiro E, Galvao-Teles A, Santos ML, et al 1986 Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. BMJ 292:227; and Foresti V, Parisio E, Scolari N, et al 1985 Amiodarone and antithyroid antibodies. Ann Intern Med 103:158.
245. Rabinowe SL, Larsen PR, Antman EM, et al 1986 Amiodarone therapy and autoimmune thyroid disease. Am J Med 81:53; see also: Monteiro E, Galvao-Teles A, Santos ML, et al 1986 Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. BMJ 292:227; and Foresti V, Parisio E, Scolari N, et al 1985 Amiodarone and antithyroid antibodies. Ann Intern Med 103:158.
246. Wimpfheimer C, Stauble M, Schadelin J, Studer H 1982 Prednisone in amiodarone-induced thyrotoxicosis. BMJ 284:1835-1836.
247. Mercer M 1992 Amioidarone-induced thyrotoxicosis responding to oral steroid therapy. Postgrad Med J 68:394.
248. De Weweire KA, Unger P, Dellwiche F, Unger J 1986 Failure to control hyperthyroidism with a thionamide after KC1O4 withdrawal in a patient with amiodarone associated thyrotoxicosis. J Endocrinol Invest 10:529.
249. Altahaus B, Bucher H, Shon H, Voigt T 1988 Therapieresistenz einer amiodarone-induzierten hyperthykreose. Schweiz Med Wschr 118:1176-1181.
250. Hennen G, Mary-Rabine L, Meurisse M 1992 Hyperthyroidies severes induites par l'iode: une urgence medicalchirurgicale. Rev Med Liege 47:237-244.
251. Farwell AP, Abend SL, Huang SK, et al 1990 Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 263:1526-1528.
252. Uzzan B, Pussard E, Leon A, et al 1990 The effects of plasmapheresis on thyroid hormone and plasma drug concenatrations in amiodarone-induced thyrotoxicosis. Br J Pharmacol 31:371-372.
253. Buttfield IH, Black ML, Hoffman MJ, et al 1965 Studies on the aetology and control of endemic goitre in New Guinea. Thesis, Adelaide.
254. Buttfield IH, Hetzel BS, Odell WD 1968 Effect of iodized oil on serum TSH determined by immunoassay in endemic goiter subjects. J Clin Endocrinol 28:1664.
255. Buttfield IH, Hetzel BS 1960 Endemic goiter in eastern New Guinea. Bull WHO 36:241-262.
256. Buttfield IH, Hetzel BS 1960 Endemic goiter in New Guinea and the prophylactic program with iodinated poppyseed oil. In: Stanbury JB (ed) Endemic Goiter. PAHO Sci Pub no. 193, Washington, p. 132.
257. Buttfield IH, Black ML, Hoffmann MH, et al 1966 Studies of the control of thyroid function in endemic goiter in Eastern New Guinea. J Clin Endocr 26:1201.
258. Hetzel BS 1973 Prophylaxis of endemic goitre. Acta Endocrinol Suppl 179:101.
259. Bautista A, Barker PA, Dunn JT, et al 1982 The effects of oral iodized oil on intelligenace, thyroid status and somatic growth in school-age children from an area of endemic goiter. Am J Clin Nutr 35:127.
260. Malamos B, Koutras DA, Mantzos J, et al 1970 Endemic goiter in Greece: Effects of iodized oil injection. Metabolism 19:569.
261. Medeiraos-Neto GA, Penna M, Monteiro K, et al 1975 The effect of iodized oil on the TSH response to TRH in endemic goiter patients. J Clin Endocrinol Metab 41:504.
262. Sankar R, Pandav CS, Ahlmed FU, et al 1995 Review of experiences with iodized oil in national programmes for control of iodine deficiency disorders. Ind J Ped 62:381.
263. Pretell EA, Torres T, Zenteno V, Cornejo M 1972 Prophylaxis of endemic goiter with iodized oil in rural Peru. In: Stanbury JB, Kroc RL (eds) Human Development and the Thyroid Gland. Plenum, New York, p. 149.
264. Thilly CH, Delange F, Ramioul L, et al 1977 Strategy of goitre and cretinism control in central Africa. Int J Epidemiol 6:43-54.
265. Lazarus JH, Parkes AB, N'Diaye JR, et al 1992 Endemic goitre in Senegal - Thyroid function, etiological factors and treatment with oral iodized oil. Acta Endocrinol 126:149-154.
266. Thilly CH, Swennen BL, Moreno-Reyes R, et al 1994 Maternal, fetal and juvenile hypothyroidism, birth weight and infant mortalitay in the etiopathogenesis of IDD spectra in Zaire and Malawi. In: Stanbury JB (ed) The Damaged Brain of Iodine Deficiency. Cognizant Communications Corp, New York, p. 241.
267. Pharoah POD, Connolly KJ 1987 A controlled trial of iodinated oil for the prevention of endemic cretinism: A long-term follow-up. Int J Epidemiol 16:68-73.
268. Clarke KH, McCullagh SF, Winekoff D 1960 The use of an intramuscular depot of iodized oil as a long-lasting source of iodine. Med J Austral 1:89.
269. Phillips DIW, Osmond C 1989 Iodine supplementation with oral or intramuscular iodized oil. A two year follow-up of a comparative trial. Int J Epidemiol 18:907-910.
270. Jonckheer MR, Blockx F, Kaivers R, Wyffels IG 1973 Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Radiol 28:194.
271. Leger AF, Laurent MF, Savoie JC 1981. Surcharge iodee et pathologie thyroidienne iatrogene. Annal d'Endocrinologie (Paris) 42:446.
272. Delange F 1974 Endemic goitre and thyroid function in Central Africa. Monographs in Paediatrics, Vol. 2. S. Karger, Basel.
273. Ranganathan S, Reddy V 1995 Human requirements of iodine & safe use of iodized salt. Indian J Med Res 102:227.
274. Martino E, Aghini-Lombardi Fillippi F, et al 1985 Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis. J Nucl Med 26:1402.
275. Herrmann J 1991 Prophylaxe und therapie der jodinduzieraten hyperthyreose. Dtsch Med Wochenschr 116:99.
276. Croxon AF, Laurent MF, Savoie J-C 1981 Surcharge iodee et pathologie thyroidienne iatrogene. Ann d Endocrinol (Paris) 42:446.
277. Leger FA, Baulieu J, Malinsky M, et al 1977 Therapeutic aspects of iodine-induced thyrotoxicosis [abstract]. Ann d' Endocrinol 38:86A.
278. Nolte W, Muller R, Hufner M 1995 Die behandlung jodinduzierter hyperthyreosen. Moglichkeiten und grenzen der pharmakotherapie, Med Klin 90:246.
279. Kobberling J, Hintze G, Becker HD 1985 Iodine-induced thyrotoxicosis - A case for subtotal thyroidectomy in severely ill patients. Klin Wschr 63:1.
280. Hershman JM, Pittman JA 1970 Response to synthetic thyrotropin-releasing hormone in man. J Clin Endocrinol Metab 31:457.
281. Rastogi GK, Dash RJ, Kannan V, Sinha MK 1973 Plasma thyrotrophin and its response to thyrotrophin releasing hormone in endemic goitre. Clin Endocrinology 2:153.
282. Kirkegaard C, Olgaard K, Biddal H, et al 1980 Different responses of serum TSH and TS to oral TRH in various types of non-toxic goitre. J Mol Med 4:67.
283. Wiener JD 1987 Plummer's disease: localized thyroid autonomy. J Endocrinol Invest 10:207.
284. Emrich D, Bahre M, Schicha H 1985 Detection and significance of thyroid autonomy in iodine-deficient goitre. In: Hall R, Kobberling J (eds) Thyroid Disorders Associated with Iodine Deficiency and Excess. Raven, New York, p. 261.
285. Joseph K, Mahlstedt J, Welcke U 1980 Autonomously functioning thyroid tissue (AFTT) during iodide prophylaxis. J Mol Med 4:87.
286. Bahre M, Hilgers R, Lindemann C, Emrich D 1988 Thyroid autonomy: sensitive detection in vivo and estimation of its functional relevance using quantified high-resolution scintigraphy. Acta Endocrinol 117:145-153.
287. Dremier S, Coppee F, Delange F, et al 1996 Thyroid autonomy: Mechanism and clinical effects. J Clin Endocrinol Metab 8:14187.
288. Van Sande J, Lamy F, Lecocq R, et al 1988 Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3′,5′-monophosphate metabolism. J Clin Endocrinol Metab 66:570.
289. Van Sande J, Mockel J, Boeynaems JM, et al 1980 Regulation of cyclic nucleotide and prostaglandin formation in normal human thyroid tissue and in autonomous nodules. J Clin Endocrinol Metab 50:776.
290. Duprez L, Parma J, Van Sande J, et al 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genetics 7:396; see also: Porcellini A, Ciullo I, Laviola L, et al 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 79:657.
291. Duprez L, Parma J, Van Sande J, et al 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genetics 7:396; see also: Porcellini A, Ciullo I, Laviola L, et al 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 79:657.
292. Ehe JWF, Wiarda KS, Bussemaker JK, et al 1980 Autonomously functioning euthyroid multinodular goitre. J Mol Med 4:39-48.
293. Mahlstedt J, Joseph K 1973 Dekompensation autonomer adenome der schildruse nach prolongierter jodzufur. D Med Wschr 98:1748.
294. Wiener JD 1987 Long-term follow-up in untreated Plummer's Disease (autonomous goiter). Clin Nue Med 12:198.
295. Cope O, Rawson RW, McArthur JW 1947 The hyperfunctioning single adenoma of the thyroid. Surg Gynecol Obstet 84:415.
296. Beckers C, de Crumbrugghe B, de Visscher M 1964 Dynamic disturbances of intrathyroid iodine metabolism in sporadic and toxic goiter. J Endocr 24:327.
297. Belfiore A, Sava L, Runello F, et al 1983 Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endocrinol Metab 56:283.
298. Studor H, Hunziker HR, Rauchti C 1978 Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters. Am J Med 65:227.
299. Nilsson G 1973 Self-limiting episodes of jodbasedow. Acta Endocrinol 74:475.
300. Miller JM, Horn RC, Block MA 1967 The autonomous functioning thyroid nodule in the evolution of nodular goiter. J Clin Endocrinol 27:1264.
301. Miller JM, Block MA 1970 Functional autonomy in multinodular goiter. JAMA 214:535.
302. Aeschimann S, Kopp PA, Kimura ET, et al 1993 Morphological and functional polymorphism within clonal thyroid nodules. J Clin Endocrinol Metab 77:846.
303. Kopp P, Kimura ET, Aeschimann S, et al 1994 Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 79:134.
304. 2+ cascades. Mol Endocrinol 9:725.
305. Bertherat J 1996 Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas: New mutants, new second messenger and new frequency. Eur J Endocrinol 134:114.
306. Porcellini A, Ciullo I, Laviola L, et al 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 79:657.
307. Haberman L, Leisner B, Witte A, et al 1982 Iodine contamination as a cause of hyperthyroidism or lack of TSH response to TRH stimulation. Results based on a screening investigation. J Endocrinol Invest 5:153.
308. Seif FJ, Stockle G, Grehn S, Steidle B 1980 Changes of thyroid hormones, thyrotropin, and prolactin after application of iodinated radiographic media in patients of an endemic goiter area. J Mol Med 4:211.
309. Kristensen HL, Vadstrup S, Knudsen N, Siersbaek-Neilsen K 1995 Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake. J Endocrinol Invest 18:41.
310. Sandrock D, Olbricht T, Emrich D, et al 1993 Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol 128:51.
311. Belfiore A, Sava L, Ruknello F, et al 1983 Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endocrinol Metab 56:283.
312. Berghout A, Weirsinga WM, Smits NJ, Touber JKL 1990 Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602; see also: Silverstein GE, Burke G, Cogan R 1967 The natural history of the autonomous hyperfunctioning thyroid nodule. Ann Intern Med 67:539.
313. Berghout A, Weirsinga WM, Smits NJ, Touber JKL 1990 Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602; see also: Silverstein GE, Burke G, Cogan R 1967 The natural history of the autonomous hyperfunctioning thyroid nodule. Ann Intern Med 67:539.
314. Hamberger JI 1980 Evolution of toxicity in solitary non-toxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 50:1089.
315. Hamberger J 1987 The autonomously functioning thyroid nodule: Goetsch's Disease. Endocr Rev 8:439.
316. Peter HJ, Gerber H, Studer H, et al 1987 Autonomy of growth and of iodinemetabolism in hyperthyroid feline goiters transplanted onto nude mice. J Clin Invest 80:491.
317. Figge JM, Leinung M, Goodman AD et al 1994 The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free TS) toxicosis. Am J Med 96:229.
318. Parle JV, Franklyn JA, Cross KW, et al 1991 Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol 34:77.
319. Stott DJ, McLellan AR, Finlayson J, et al 1990 Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. QJM 78:77; see also: Studor H, Hunziger HR, Ruchti G 1978 Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters. Am J Med 65:227.
320. Stott DJ, McLellan AR, Finlayson J, et al 1990 Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. QJM 78:77; see also: Studor H, Hunziger HR, Ruchti G 1978 Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters. Am J Med 65:227.
321. Bondi B, Fazio S, Carella C, et al 1993 Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334.
322. Banovac K, Papic M, Busker MS, et al 1989 Evidence of hyperthyroidism in apparently euthyroid patients treated with levothyroxine. Arch Intern Med 149:809.
323. Fazio S, Bondi B, Carella C, et al 1995 Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of b-blockade. J Clin Endocrinol Metab 80:2222.
324. Sawin CT, Geller A, Wolf PA, et al 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249.
325. Ross DS 1988 Subclinical hyperthyroidism: Possible danger of overzealous thyroxine replacement therapy. Mayo Clinic Proc 63:1223.
326. Braverman LE, Eber O, Langsteger W (eds) 1994 Heart and Thyroid. Blackwell-MZV, Vienna.
327. Woeber KA 1993 Thyrotoxicosis and cardiac disease. Heart Dis Stroke 2:415.
328. Monreal M, Lafoz D, Foz M, et al 1988 Occult thyrotoxicosis in patient with atrial fibrillation and an acute arterial embolism. Angiology 39:981.
329. Surks MI, Ocampo E 1996 Subclinical thyroid disease. Am J Med 100:217.
330. Gemsenjager E, Staug JJ, Gizzard J, Heitz P 1976 Preclinical hyperthyroidism in multinodular goitre. J Clin Endocrinol Metab 43:810.
331. Klein M, Pascal V, Aubert V, et al 1995 Coeur et thyroide. Ann d'Endocrinol 56:473; see also: Woeber KA 1993 Thyrotoxicosis and cardiac disease. Heart Dis Stroke 2:415-417.
332. Klein M, Pascal V, Aubert V, et al 1995 Coeur et thyroide. Ann d'Endocrinol 56:473; see also: Woeber KA 1993 Thyrotoxicosis and cardiac disease. Heart Dis Stroke 2:415-417.
333. Ebisawa K, Ikeda U, Murata M, et al 1994 Irreversible cardiomyopathy due to thyrotoxicosis. Cardiology 84:274.
334. Ridgway CE 1994 Cardiac consequences of subclinical hyperthyroidism. In: Braverman LE, Eber O, Langsteger W (eds) Heart and Thyroid. Blackwell-MZV, Vienna, p. 60.
335. Forfar JC, Muir AL, Sawers SA, Toft AD 1982 Abnormal left ventricular function in hyperthyroidism. N Engl J Med 307:1165.
336. Lombardi G, Biondi B, Fazio S, et al 1994 Long term 1-thyroxine supressive therapy and heart. In: Braverman LE, Eber O, Langsteger W (eds) Heart and Thyroid. Blackwell-MZV, Vienna, p. 86.
337. Ross DS 1988 Subclinical hyperthyroidism: Possible danger of overzealous thyroxine replacement therapy. Mayo Clinic Proc 63:1988.
338. Bell GM, Sawers JSA, Forfar JC, et al 1983 The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin Endocrinol 18:511-516.
339. Biondi B, Fazio S, Carella C, et al 1993 Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334-338.
340. Parker JLW, Lawson DH 1973 Death from thyrotoxicosis. Lancet ii:894.
341. Banovac K, Papic M, Bilaker MS, et al 1989 Evidence of hyperthyroidism in apparently euthyroid patients treated with levothyroxine. Arch Intern Med 149:809.
342. Bar-Bela S, Ehrenfeld M, Eliakim M 1981 Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med 141:1191-1192.
343. Petersen P, Hansen JM 1988 Stroke in thyrotoxicosis with atrial fibrillation. Stroke 19:15.
344. Staffurth JS, Gibberd MC, Fui SNT 1977 Arterial embolism in thyrotoxicosis with atrial fibrillation. BMJ 2:688.
345. Georges JL, Normand JP, Lenormand ME, Schwob J 1992 Life-threatening thyrotoxicosis induced by amiodarone in patients with benign heart disease. Eur Heart J 13:129-192.
346. Hurley DM, Hunter AN, Hewett MJ, Stockigt JR 1981 Atrial fibrillation and arterial embolism in hyperthyroidism. Aust N Z J Med 11:391-393.
347. Yuen RWM, Gutteridge DH, Thompson PL, Robinson JS 1979 Embolism in thyrotoxic atrial fibrillation. Med J Aust 1:630-631.
348. Ross DS, Neer RM, Ridgway EC, Daniels GH 1987 Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with 1-thyroxine. Am J Med 82:467.